MedTrace Logo

Giessen Pulmonary Hypertension in Lung Cancer Registry

NCT04467333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-04-01

No results posted yet for this study

Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Conditions

  • Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Interventions

OTHER

All lung cancer patients.

There will be no specific interventions. All patients will receive guidelines based therapy of lung cancer and their comorbidities.

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Principal Investigators

  • Bastian Eul, MD · JLU Giessen

  • Khodr Tello, MD · JLU Giessen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2026-01-29
Completion
2040-01-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04467333 on ClinicalTrials.gov